Literature DB >> 1887461

Travel medicine--prevention based on epidemiological data.

R Steffen1.   

Abstract

In travel medicine efforts should be concentrated on preventive measures that are necessary, and travellers should be spared the side effects, costs and stress of superfluous measures. Excess mortality abroad is mainly due to traffic and swimming accidents, indicating the need for appropriate control strategies. The morbidity in travellers to developing countries is high, and is primarily due to traveller's diarrhoea. As prophylaxis is ineffective or unrealistic, and as travellers often need fast relief, it is recommended to include loperamide and an antimicrobial agent in the travel kit. Recent studies have shown that the incidence rate per month of Plasmodium falciparum malaria in Africa may reach 24/1000. The most frequently occurring immunizable diseases are hepatitis A (3/1000) and hepatitis B (0.8/1000). For many tourists and some expatriates pre-travel advice (hygiene, measures against mosquito bites, etc.) as well as chemoprophylaxis and immunization can be limited to these infections, but those travelling or staying outside large centres need additional measures.

Entities:  

Mesh:

Year:  1991        PMID: 1887461     DOI: 10.1016/0035-9203(91)90005-j

Source DB:  PubMed          Journal:  Trans R Soc Trop Med Hyg        ISSN: 0035-9203            Impact factor:   2.184


  7 in total

1.  Bipolar disorder after mefloquine treatment.

Authors:  C Even; S Friedman; K Lanouar
Journal:  J Psychiatry Neurosci       Date:  2001-05       Impact factor: 6.186

2.  Prevalence of hepatitis A antibodies in Swiss travellers.

Authors:  S Studer; H I Joller-Jemelka; R Steffen; P J Grob
Journal:  Eur J Epidemiol       Date:  1993-01       Impact factor: 8.082

3.  Mefloquine versus quinine plus sulphalene-pyrimethamine (metakelfin) for treatment of uncomplicated imported falciparum malaria acquired in Africa.

Authors:  Alberto Matteelli; Nuccia Saleri; Zeno Bisoffi; Giampietro Gregis; Giovanni Gaiera; Raffaella Visonà; Simona Tedoldi; Carla Scolari; Stefania Marocco; Maurizio Gulletta
Journal:  Antimicrob Agents Chemother       Date:  2005-02       Impact factor: 5.191

4.  Travel counsellors and travel health advice.

Authors:  Caroline D McAllister; Margaret L Russell
Journal:  Can J Public Health       Date:  2004 Mar-Apr

5.  Is travel prophylaxis worth while? Economic appraisal of prophylactic measures against malaria, hepatitis A, and typhoid in travellers.

Authors:  R H Behrens; J A Roberts
Journal:  BMJ       Date:  1994-10-08

6.  Identification of a Syndrome Class of Neuropsychiatric Adverse Reactions to Mefloquine from Latent Class Modeling of FDA Adverse Event Reporting System Data.

Authors:  Remington L Nevin; Jeannie-Marie Leoutsakos
Journal:  Drugs R D       Date:  2017-03

Review 7.  The role of the traveler in emerging infections and magnitude of travel.

Authors:  Lin H Chen; Mary Elizabeth Wilson
Journal:  Med Clin North Am       Date:  2008-11       Impact factor: 5.456

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.